Multiple Sclerosis is an unpredictable auto-immune disease of the body’s central neurological system. This system includes the brain, spinal cord, and optic nerves, controlling everything we do. Disrupting the flow of information in the brain, and between the brain and body, MS may present differently from day to day, year to year, and vary from person to person. Symptoms such as Fatigue, memory difficulties, mood changes, mobility difficulties, vision impairment, numbness, pain, and tingling can affect different parts of the body and occur at different times. Inflammation and damage will cause the symptoms to appear wherever it is happening in the body (National Multiple Sclerosis Society, 2019).<\/p>\n
The outlook for Multiple Sclerosis (MS) at the start of 2025 is promising, with several breakthroughs and advancements in treatments having emerged.<\/p>\n
Recent studies support the early use of high-efficacy disease-modifying therapies (DMTs) for better long-term outcomes. Research from the Swedish MS Registry indicates that starting with high-efficacy treatments can reduce the rate of disability progression. This helps clinicians evaluate the right treatment for an individual. As there are dozens of approved therapies available to treat MS, finding the right one can be a challenge. The new research promotes a starting strong approach with a higher efficacy therapy that may have more significant side effects but with greater benefits. Clinicians and patients can justify that risk compared to the start low and go-slow approach that leverages moderate efficacy therapies with less risk of side effects now that new data supports using higher-efficacy DMTs early in treatment. (Hoff Communications, 2024).<\/p>\n
Scientists at the University of California San Francisco are optimistic about finding a cure for MS in the near future. UCSF Weil Institute for Neuroscience, led by Dr. Stephen Hauser, focuses new research on targeting B cells, which play a crucial role in MS\u2019s progression. The center is investigating ways to treat MS sooner, more aggressively, and with new more powerful medications. The center has advanced research that could lead to therapies that reverse symptoms or even treat MS before it begins (A Cure for Multiple Sclerosis? Scientists Say within Our Lifetime, 2024).<\/p>\n
The National MS Society has updated its Pathways to Cures Roadmap, highlighting research areas with the greatest potential to stop MS, restore function, and repair damage. This roadmap is endorsed by 30 MS organizations worldwide and highlights the most promising areas for future research. The Pathways to Cures Roadmap first established in 2022 outlines the research needed for each of three specific pathways: Stop, Restore, and End. In addition, the Roadmap highlights the key factors necessary to accelerate progress in research: global data sharing, enhanced collaboration, sustained funding commitments, patients, regulators, and payers engagement, and equity and inclusion efforts globally. The Global Landscape Assessment highlighted more than 2.300 research projects worth close to $2 billion. This helps to guide the community to the best focus and investment areas where increased potential impact can be maximized (National Multiple Sclerosis Society, 2019).<\/p>\n
As shared at this year\u2019s Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024, studies continue to explore the safety and efficacy of repeated stem cell transplants for MS patients. Stem cells from a patient\u2019s own body tissues are treated and amplified, then reintroduced to the patient\u2019s body, which has been prepared by a course of powerful drugs to clear out the immune system, thereby essentially resetting the immune system with the treated stem cells. This approach has shown good potential in managing MS and improving patients’ quality of life (Hoff Communications, 2024).<\/p>\n
Studies presented at September\u2019s 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) emphasize the roles of exercise, diet, and sleep in managing MS and enhancing an individual\u2019s quality of life. One study showed that people with MS who followed a Mediterranean Diet had better mental health and quality of life. Ongoing research is looking at whether the diet slows the progression of physical disability in Multiple Sclerosis. The research shows promise. French researchers have shown that bi-weekly high vitamin D3 doses have also been shown to be beneficial in reducing MS activity after the initial demyelinating event. And a Danish study showed that good sleep promoted better quality of life and Functional Assessment of MS (FAMS) scores among patients (Hoff Communications, 2024).<\/p>\n
These advancements offer hope for improved management and potential cures for MS in the near future. Until then, if you or a loved one needs assistance with daily care because of MS symptoms and have questions about assisted living facilities, reach out to us, we are happy to help. Our specialty is knowing which facilities meet our clients\u2019 needs best, including the right type of care, financial fit, and personal preferences.<\/p>\n
References:<\/strong><\/p>\n (2019). Nationalmssociety.org. https:\/\/www.nationalmssociety.org\/understanding-ms\/what-is-ms<\/p>\n (2019). Nationalmssociety.org. https:\/\/www.nationalmssociety.org\/news-and-magazine\/news\/refined-pathways-to-cures-roadmap-published<\/p>\n A Cure for Multiple Sclerosis? Scientists Say Within Our Lifetime. (2024, June 12). A Cure for Multiple Sclerosis? Scientists Say within Our Lifetime | UC San Francisco. https:\/\/www.ucsf.edu\/news\/2024\/06\/427831\/cure-multiple-sclerosis-scientists-say-within-our-lifetime<\/p>\n \u200cHoff Communications. (2024, March 28). What\u2019s New in MS Research – March 2024 | MSAA. MSAA. https:\/\/mymsaa.org\/news\/whats-new-in-ms-research-march-2024\/<\/p>\n Hoff Communications. (2024, November 22). What\u2019s New in MS Research – November 2024 | MSAA. MSAA. https:\/\/mymsaa.org\/news\/whats-new-in-ms-research-november-2024\/ <\/p>\n","protected":false},"excerpt":{"rendered":" Research, breakthroughs and treatments Multiple Sclerosis is an unpredictable auto-immune disease of the body’s central neurological system. This system includes the brain, spinal cord, and optic nerves, controlling everything we do. Disrupting the flow of information in the brain, and between the brain and body, MS may present differently from day to day, year to…<\/p>\n","protected":false},"author":1,"featured_media":8107,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-8106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources-information"],"acf":[],"_links":{"self":[{"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/posts\/8106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/comments?post=8106"}],"version-history":[{"count":1,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/posts\/8106\/revisions"}],"predecessor-version":[{"id":8678,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/posts\/8106\/revisions\/8678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/media\/8107"}],"wp:attachment":[{"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/media?parent=8106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/categories?post=8106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carepatrol.com\/baltimore\/wp-json\/wp\/v2\/tags?post=8106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u200c<\/p>\n